Westport Resources Management’s United Therapeutics UTHR Stock Holding History

Westport Resources Management’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-360	Closed	-$38K	–	675
2016 Q2	$38K	Hold	360	–	–	0.01%	434
2016 Q1	$40K	Hold	360	–	–	0.01%	429
2015 Q4	$56K	Hold	360	–	–	0.02%	438
2015 Q3	$47K	Hold	360	–	–	0.01%	478
2015 Q2	$63K	Hold	360	–	–	0.02%	454
2015 Q1	$62K	Hold	360	–	–	0.02%	481
2014 Q4	$47K	Buy	360 +250	+227%	+$32.2K	0.01%	556
2014 Q3	$14K	Buy	+110	New	+$11.3K	﹤0.01%	785

Other funds holding UTHR

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Westport Resources Management's UTHR Position: Q3 2016 in Review

Westport Resources Management sold out of United Therapeutics (UTHR) in Q3 2016, closing a stake of 360 shares — an estimated $38K sold.

Westport Resources Management first reported a position in UTHR in Q3 2014 and held it in 8 quarters. The position peaked at $63K in Q2 2015. 394 funds tracked by Wall St. Rank hold UTHR as of Q3 2016.

Westport Resources Management reported no remaining United Therapeutics position as of Q3 2016 after selling out during the quarter.
Westport Resources Management sold 360 United Therapeutics shares in Q3 2016, an estimated $38K.
Westport Resources Management first reported a position in United Therapeutics in Q3 2014 and held it in 8 quarters.
Westport Resources Management's United Therapeutics position peaked at $63K in Q2 2015.
394 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2016.

Based on Westport Resources Management's 13F filing for Q3 2016, filed 14 Nov 2016.